De Novo Donor-Specific Human Leukocyte Antigen Antibodies Early After Kidney Transplantation-Reference-Cited by-同舟云学术

De Novo Donor-Specific Human Leukocyte Antigen Antibodies Early After Kidney Transplantation

Published:2014-12-27 Issue:12 Volume:98 Page:1310-1315
ISSN:0041-1337
Container-title:Transplantation
language:en
Short-container-title:

Author:

Heilman Raymond L.,Nijim Ala,Desmarteau Yvonne M.,Khamash Hasan,Pando Marcelo Jorge,Smith Maxwell L.,Chakkera Harini A.,Huskey Janna,Valdez Riccardo,Reddy Kunam Sudhakar

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Transplantation

Reference19 articles.

1. Evolution and clinical pathologic correlations of de novo donor-specific HLA antibody post kidney transplant.;Wiebe;Am J Transplant,2012

2. Evidence for antibody-mediated injury as a major determinant of late kidney allograft failure.;Gaston;Transplantation,2010

3. Posttransplant de novo donor-specific HLA antibodies identify pediatric kidney recipients at risk for late antibody-mediated rejection.;Ginevri;Am J Transplant,2012

4. Reducing de novo donor-specific antibody levels during acute rejection diminishes renal allograft loss.;Everly;Am J Transplant,2009

5. A new equation to estimate glomerular filtration rate.;Levey;Ann Intern Med,2009

Cited by 62 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Antibody-Suppressor CXCR5+CD8+ T Cells Are More Potent Regulators of Humoral Alloimmunity after Kidney Transplant in Mice Compared to CD4+ Regulatory T Cells;The Journal of Immunology;2024-03-22

2. What Do Donor-Specific Antibody Changes Mean in Kidney Transplant Patients?;Turkish Journal of Internal Medicine;2023-10-29

3. The Clinical Utility of Post-Transplant Monitoring of Donor-Specific Antibodies in Stable Renal Transplant Recipients: A Consensus Report With Guideline Statements for Clinical Practice;Transplant International;2023-07-25

4. Comparison of high-dose IVIG and rituximab versus rituximab as a preemptive therapy for de novo donor-specific antibodies in kidney transplant patients;Scientific Reports;2023-05-11

5. Association of Circulating Anti-HLA Donor-Specific Antibodies and Their Characteristics, including C1q-Binding Capacity, in Kidney Transplant Recipients with Long-Term Renal Graft Outcomes;Journal of Clinical Medicine;2023-02-07